| Autor: |
Eltabbakh GH; Division of Gynecologic Oncology, University of Vermont, Burlington 05401, USA., Moody J, Garafano LL, Hammond JM |
| Jazyk: |
angličtina |
| Zdroj: |
European journal of gynaecological oncology [Eur J Gynaecol Oncol] 1999; Vol. 20 (1), pp. 18-9. |
| Abstrakt: |
Uterine papillary serous adenocarcinoma is an uncommon and very aggressive type of endometrial cancer. A 76-year-old patient diagnosed with recurrent uterine papillary serous adenocarcinoma was prescribed megesterol acetate (160 mg daily), paclitaxel (135 mg/m2) and carboplatin (area under the concentration-time curve of 5) every 4 weeks for 4 courses. She demonstrated complete clinical response that was maintained for longer than 6 months with minimal toxicity. The combination megesterol acetate, paclitaxel and carboplatin may be effective in women with recurrent uterine papillary serous adenocarcinoma. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
